300357 我武生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)13.82414.00514.89618.77321.178
总资产报酬率 ROA (%)12.31212.05913.03316.89019.113
投入资产回报率 ROIC (%)13.62613.57314.42118.50621.113

边际利润分析
销售毛利率 (%)95.37495.15895.26295.39395.736
营业利润率 (%)46.60439.88740.67244.21948.645
息税前利润/营业总收入 (%)43.75536.15737.31241.79945.914
净利润/营业总收入 (%)39.28432.88734.84137.46940.398

收益指标分析
经营活动净收益/利润总额(%)99.84594.99496.618102.51594.079
价值变动净收益/利润总额(%)0.4671.7720.3600.6761.600
营业外收支净额/利润总额(%)-0.867-1.1090.2840.6370.023

偿债能力分析
流动比率 (X)14.7759.0458.86714.37612.422
速动比率 (X)14.3278.7298.53413.90511.924
资产负债率 (%)5.5999.23910.0887.7697.006
带息债务/全部投入资本 (%)-0.825-0.6390.467-1.137-1.068
股东权益/带息债务 (%)-12,030.274-15,316.14920,537.318-8,595.943-9,315.131
股东权益/负债合计 (%)1,627.187940.372845.4291,159.3041,282.590
利息保障倍数 (X)-17.871-10.984-10.734-15.460-16.742

营运能力分析
应收账款周转天数 (天)65.87457.57166.65065.73464.711
存货周转天数 (天)381.102469.069481.237445.498533.562